Michael Nofi

Insider Reports History

Location
Stamford, CT
Signature
/s/ John R. Moore, Attorney-in-Fact for Michael Nofi
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael Nofi:

Company Role Class Num Shares Value Price $ Report Date Ownership
SpringWorks Therapeutics, Inc. Chief Accounting Officer Common Stock 0 $0 $46.74 01 Jul 2025 Direct
Edgewise Therapeutics, Inc. Chief Financial Officer Stock Options (Right to buy) 262,500 10 Nov 2025 Direct
Edgewise Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 43,750 10 Nov 2025 Direct
SpringWorks Therapeutics, Inc. Chief Accounting Officer Performance Share Units 0 01 Jul 2025 Direct
SpringWorks Therapeutics, Inc. Chief Accounting Officer Stock Option (Right to Buy) 0 01 Jul 2025 Direct

Insider Reports Filed by Michael Nofi

Symbol Company Period Transactions Value $ Form Type Role Filing Time
EWTX Edgewise Therapeutics, Inc. 10 Nov 2025 2 $0 4 Chief Financial Officer 13 Nov 2025, 18:03
EWTX Edgewise Therapeutics, Inc. 10 Nov 2025 0 $0 3 Chief Financial Officer 13 Nov 2025, 18:01
SWTX SpringWorks Therapeutics, Inc. 01 Jul 2025 6 $0 4 Chief Accounting Officer 02 Jul 2025, 16:20
SWTX SpringWorks Therapeutics, Inc. 10 Jan 2025 2 $0 4 Chief Accounting Officer 14 Jan 2025, 16:35
SWTX SpringWorks Therapeutics, Inc. 04 Jan 2025 3 -$192,886 4 Chief Accounting Officer 07 Jan 2025, 19:16
SWTX SpringWorks Therapeutics, Inc. 04 Jan 2024 4 -$88,522 4 Chief Accounting Officer 08 Jan 2024, 21:11
SWTX SpringWorks Therapeutics, Inc. 07 Jan 2023 1 -$10,802 4 Chief Accounting Officer 10 Jan 2023, 15:08
SWTX SpringWorks Therapeutics, Inc. 05 Jan 2023 4 -$21,548 4 Chief Accounting Officer 09 Jan 2023, 16:00
SWTX SpringWorks Therapeutics, Inc. 07 Jan 2022 1 -$23,209 4/A Chief Accounting Officer 14 Jan 2022, 15:59
SWTX SpringWorks Therapeutics, Inc. 06 Jan 2022 2 $0 4 Chief Accounting Officer 10 Jan 2022, 15:22